CGAS and bladder transitional cell carcinoma: In order to elucidate whether the expression levels of four genes were influenced by the state of the cGAS-STING pathway, we employed varying concentrations of ADU-S100 (a cGAS-STING pathway agonist) to treat the T24 cell line of BLCA.